Developed with US respiratory specialist firm Innoviva, the drug (known as Breo Ellipta in the US ... not adequately controlled on low or medium dose inhaled corticosteroids.

The drug, known as Breo Ellipta in the US ... and can be expected to frequently deliver a dose of harsh reality. Read more about the Salford Lung Study from GSK here Read the 2014 paper by ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Dosing a statin (rosuvastatin) every other day (EOD) may provide significant lipoprotein changes while avoiding common adverse effects in this statin-intolerant population. Objective: To determine ...